TD Cowen Initiates Coverage On Adarx Pharmaceuticals with Buy Rating

Benzinga · 3d ago
TD Cowen analyst Tyler Van Buren initiates coverage on Adarx Pharmaceuticals (NASDAQ:ADRX) with a Buy rating.